Semanext Reusable Pen

The Semanext Reusable Pen Injector is a reusable injection pen developed by Cipla Ltd. It is designed to administer Semaglutide, a synthetic form of parathyroid hormone (PTH), used to treat osteoporosis. Osteoporosis is a condition characterised by weakened bones, which increases the risk of fractures. This device facilitates the subcutaneous injection of Semaglutide, promoting bone formation and strength. It's important to note that the Semanext Reusable Pen Injector does not contain any medication itself. It must be used in conjunction with Semanext cartridges containing Semaglutide and Semanext Pen Needles. Before using this device, consult with a healthcare professional to ensure proper usage and to discuss any potential risks or contraindications.

The Semasize Reusable Pro Pen is used to administer Semaglutide for: Weight management in adults with obesity. Weight management in overweight adults with at least one weight-related health condition. Supporting weight loss when combined with a reduced-calorie diet and increased physical activity.

To use the Semanext Reusable Pen Injector: Wash your hands thoroughly. Attach a new needle to the pen. Insert the Semanext cartridge containing Semaglutide into the pen. Set the prescribed dose as directed by your healthcare provider. Clean the injection site (thigh or abdomen) with an alcohol swab. Inject the medication subcutaneously as instructed. Remove and dispose of the needle safely after each use. Always follow the instructions provided by your healthcare provider or the device manual for proper usage.

Common Side Effects: Injection site reactions (pain, redness, swelling) Nausea Leg cramps Dizziness Serious Side Effects: Hypercalcemia (elevated calcium levels) Allergic reactions (rash, itching, swelling) Osteosarcoma (a rare type of bone cancer) If you experience any severe side effects, discontinue use and consult your healthcare provider immediately.

2 - 8°C